DaVita Inc. Files 8-K
Ticker: DVA · Form: 8-K · Filed: Aug 20, 2025 · CIK: 927066
| Field | Detail |
|---|---|
| Company | Davita Inc. (DVA) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $2,000,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
DaVita filed an 8-K, something happened, details TBD.
AI Summary
DaVita Inc. filed an 8-K on August 20, 2025, reporting an event under "Other Events." The filing does not contain specific details about the event, dollar amounts, or names beyond the company itself.
Why It Matters
This filing indicates a material event has occurred for DaVita Inc., requiring disclosure to investors, though the specifics are not yet detailed.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not contain specific financial or operational information that would immediately indicate risk.
Key Players & Entities
- DAVITA INC. (company) — Registrant
- August 20, 2025 (date) — Date of Report
- 2000 16th Street Denver, CO 80202 (address) — Principal executive offices
FAQ
What specific event is DaVita Inc. reporting under 'Other Events'?
The provided filing excerpt does not specify the nature of the 'Other Events' being reported.
When was this 8-K filing submitted?
The filing was submitted on August 20, 2025.
What is DaVita Inc.'s principal executive office address?
DaVita Inc.'s principal executive offices are located at 2000 16th Street, Denver, CO 80202.
What is DaVita Inc.'s IRS Employer Identification Number (EIN)?
DaVita Inc.'s EIN is 51-0354549.
What is the Commission File Number for DaVita Inc.?
DaVita Inc.'s Commission File Number is 001-14106.
Filing Stats: 811 words · 3 min read · ~3 pages · Grade level 14.8 · Accepted 2025-08-20 16:09:40
Key Financial Figures
- $0.001 — nge on which registered: Common Stock, $0.001 par value DVA New York Stock Exchange
- $2,000,000,000 — 's existing share repurchase program by $2,000,000,000 in additional repurchasing authority (t
Filing Documents
- dva-20250820.htm (8-K) — 27KB
- 0000927066-25-000154.txt ( ) — 142KB
- dva-20250820.xsd (EX-101.SCH) — 2KB
- dva-20250820_lab.xml (EX-101.LAB) — 21KB
- dva-20250820_pre.xml (EX-101.PRE) — 12KB
- dva-20250820_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On August 20, 2025, the board of directors (the "Board") of DaVita Inc. (the "Company") increased the authorization under the Company's existing share repurchase program by $2,000,000,000 in additional repurchasing authority (the "New Authorization"). The amount of shares of common stock authorized to be repurchased under the New Authorization does not include the amount remaining under the Company's existing share repurchase program authorized on September 5, 2024 (the "Existing Authorization"). The Existing Authorization and the New Authorization do not have an expiration date and do not obligate the Company to purchase any shares. Repurchases under the New Authorization and the Existing Authorization may take place in the open market or in privately negotiated transactions, including without limitation, pursuant to the Company's share repurchase agreement, dated as of April 30, 2024 with Berkshire Hathaway Inc. (the "Berkshire Share Repurchase Agreement"), on behalf of itself and its affiliates, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing. There can be no assurance as to the precise number of shares that will be repurchased under the Existing Authorization or the New Authorization, the aggregate dollar amount of the shares purchased, or the ultimate disposition of the shares purchased (re-issued, retained in treasury and/or retired). Depending on market conditions, regulatory, legal and contractual requirements and other factors, repurchases may be made at any time or from time to time, without prior notice. The Company may suspend or discontinue the Existing Authorization and/or the New Authorization, or increase or decrease the amount of shares authorized to be repurchased thereunder, at any time. The Company remains subject to certain share repurchase limitations, including under the terms of its current senior secured credit faciliti
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws. All such statements in this report, other than statements of historical fact, are forward-looking statements. Words such as "expect," "intend," "will," "plan," "anticipate," "may," "believe," "continue," and similar expressions are intended to identify forward-looking statements. The Company bases its forward-looking statements on information available to it on the date of this report, and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may otherwise be required by law. Actual results and other events could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the risk factors set forth in the Company's reports on Form 10-K and Form 10-Q and the other risks and uncertainties discussed in any subsequent reports that the Company files with the Securities and Exchange Commission from time to time.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DAVITA INC. Date: August 20, 2025 By: /s/ Joel Ackerman Joel Ackerman Chief Financial Officer and Treasurer